GenScript Biotech's spinoff Legend Biotech, which counts Eli Lilly and Johnson & Johnson as backers, floated in the US.

The shopping delivery app developer, which counts Comcast, American Express and Amazon among its investors, boosted its valuation to $13.7bn in the round.

LY.com's group buying grocery spinoff raised the money in a Joyy-led round also backed by existing investors including Bertelsmann Asia Investments and Legend Capital.

The fraud prevention software provider closed a series A round co-led by Axa Venture Partners that will support international growth and product development.

Johnson & Johnson Innovation – JJDC returned for Cue Health’s $100m series C round as the medical diagnostics system developer seeks regulatory approval for its Covid-19 test.

The cancer immunotherapy developer's latest round included pharmaceutical producers and co-founders Juno Therapeutics and WuXi AppTec.

Existing backer GV returned to take part in a $100m round for the Stanford spinout that also attracted new investor Regeneron Pharmaceuticals.

Existing backer GV returned to take part in a $100m round for the clinical data software provider that also attracted new investor Regeneron Pharmaceuticals.

TU Munich's air taxi developer has added $35m from Bailie Gifford to a $240m first tranche led by Tencent in March, and is now valued above $1bn.

Legend Capital co-led a $282m series B round for chipmaker Eswin Computing Technology which will use the money to fund R&D, recruitment and manufacturing.